Cleveland Biolabs (CBLI) Reports Q1 Loss of $1.14
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q1 EPS of ($1.14), versus ($0.63) reported last year. Revenue for the quarter came in at $607.33 thousand versus the consensus estimate of $1.33 million.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
